Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Express Scripts
Moodys
UBS
AstraZeneca
Accenture
McKinsey
Mallinckrodt
Federal Trade Commission
US Department of Justice

Generated: October 18, 2017

DrugPatentWatch Database Preview

Cyclopentolate hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for cyclopentolate hydrochloride and what is the scope of cyclopentolate hydrochloride patent protection?

Cyclopentolate hydrochloride
is the generic ingredient in six branded drugs marketed by Novartis Pharms Corp, Akorn Inc, Pharmafair, Sola Barnes Hind, Akorn, Alcon Pharms Ltd, and Bausch And Lomb, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for cyclopentolate hydrochloride. Seven suppliers are listed for this compound.

Summary for Generic Name: cyclopentolate hydrochloride

US Patents:0
Tradenames:6
Applicants:7
NDAs:14
Drug Master File Entries: see list2
Suppliers / Packagers: see list7
Bulk Api Vendors: see list26
Clinical Trials: see list2,287
Patent Applications: see list862
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cyclopentolate hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sola Barnes Hind
CYCLOPENTOLATE HYDROCHLORIDE
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC084863-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Akorn
AK-PENTOLATE
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC085555-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
CYCLOGYL
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC084109-001Approved Prior to Jan 1, 1982ATRXNoYes► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
CYCLOMYDRIL
cyclopentolate hydrochloride; phenylephrine hydrochloride
SOLUTION/DROPS;OPHTHALMIC084300-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe
Akorn
AKPENTOLATE
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC040165-001Jan 13, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Sola Barnes Hind
CYCLOPENTOLATE HYDROCHLORIDE
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC084150-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmafair
PENTOLAIR
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC088150-001Feb 25, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
CYCLOGYL
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC084110-001Approved Prior to Jan 1, 1982ATRXNoYes► Subscribe► Subscribe► Subscribe
Akorn Inc
CYCLOPENTOLATE HYDROCHLORIDE
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC205937-001Dec 9, 2015ATRXNoNo► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
CYCLOGYL
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC084108-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
McKesson
Citi
Chubb
Dow
Farmers Insurance
Argus Health
Boehringer Ingelheim
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot